Granted Patent
B2
US 8,114,967 · App. 12/056,151 · Granted Feb 14, 2012
Constructs and libraries comprising antibody surrogate light chain sequences
Assignee:
Sea Lane Biotechnologies LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention concerns constructs and libraries comprising antibody surrogate light chain sequences. In particular, the invention concerns constructs comprising VpreB sequences, optionally partnered with another polypeptide, such as, for example, antibody heavy chain variable domain sequences, and libraries containing the same.
Claims (1)
1. A polypeptide comprising amino acid residues from 1 to about 116-126 of the VpreB1 sequence of SEQ ID NO: 1, fused directly, at its C-terminus to the N-terminus of amino acid residues from about 82-93 to 209 of the λ5 sequence of SEQ ID NO: 5, conjugated to an antibody heavy chain sequence comprising a variable region to form a conjugate, wherein the conjugate specifically binds a target.
Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 2, 2025
From: REVOPSIS THERAPEUTICS, INC.
To: REVOPSIS HOLDINGS, LLC
Reel/Frame 072793/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 8, 2024
From: BIOASSETS, LLC
To: REVOPSIS THERAPEUTICS, INC.
Reel/Frame 066055/0107 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 20, 2023
From: I2 PHARMACEUTICALS, INC.
To: BIOASSETS, LLC
Reel/Frame 064003/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 21, 2016
From: HOROWITZ, LAWRENCE; BHATT, RAMESH; XU, LI
To: SEA LANE BIOTECHNOLOGIES, LLC.
Reel/Frame 041130/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 21, 2016
From: SEA LANE BIOTECHNOLOGIES, LLC.
To: ALTUS BIOPHARMA INC.
Reel/Frame 041154/0070 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 21, 2016
From: ALTUS BIOPHARMA INC.
To: I2 PHARMACEUTICALS, INC.
Reel/Frame 041154/0613 →
Continuity (2)
Provisional Application
60920568
· Mar 27, 2007